These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18299847)

  • 1. [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty].
    Bailly N; Dunewa I; Schlattmann P; Rieck PW
    Ophthalmologe; 2008 May; 105(5):457-62. PubMed ID: 18299847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
    Reinhard T; Reis A; Böhringer D; Malinowski M; Voiculescu A; Heering P; Godehardt E; Sunmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Jun; 239(5):367-72. PubMed ID: 11482341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats.
    Vallelado AI; López MI; Calonge M; Sánchez A; Alonso MJ
    Curr Eye Res; 2002 Jan; 24(1):39-45. PubMed ID: 12187493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
    Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R
    Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
    Mahlberg K; Uusitalo RJ; Oksala O
    Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.
    Hill JC
    Ophthalmology; 1994 Jan; 101(1):128-33. PubMed ID: 8302545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study.
    Poon AC; Forbes JE; Dart JK; Subramaniam S; Bunce C; Madison P; Ficker LA; Tuft SJ; Gartry DS; Buckley RJ
    Br J Ophthalmol; 2001 Dec; 85(12):1464-9. PubMed ID: 11734522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
    Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
    Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cyclosporine in pediatric keratoplasty.
    Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
    Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection.
    Lee SS; Kim H; Wang NS; Bungay PM; Gilger BC; Yuan P; Kim J; Csaky KG; Robinson MR
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2023-9. PubMed ID: 17460256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
    Chow SP; Cook SD; Tole DM
    Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
    Marques RE; Leal I; Guerra PS; Barão RC; Quintas AM; Rodrigues W
    Eur J Ophthalmol; 2022 May; 32(3):1469-1481. PubMed ID: 34231398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit.
    de Rojas Silva MV; Rodríguez-Ares MT; Sánchez-Salorio M; Lamas Díaz MJ; Cuevas Alvarez J; Vila Jato JL; Capeans Tomé C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):840-7. PubMed ID: 10502059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
    Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
    Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty.
    Lee JJ; Kim MK; Wee WR
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1111-9. PubMed ID: 25896110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.